Bank of New York Mellon Corp Reduces Stock Position in Bruker ...
π Bank of New York Mellon Corp cut its Bruker stake by 6.6% in Q1, reducing holdings to 780,955 shares worth $28.2 million.
π Parallel Advisors LLC significantly increased its position by 121.0% in Q4, now owning 875 shares valued at $41,000.
π Bruker reported Q1 EPS of $0.31, surpassing the consensus estimate of $0.23 with revenue of $823.4 million.
π― The company raised its FY 2026 EPS guidance to a range of $2.10-$2.15, matching average analyst expectations.
π° Bruker paid a quarterly dividend of $0.05 per share on July 7th with an ex-dividend date of June 22nd.
π Analyst consensus remains 'Hold' with an average price target of $56.79, though Citigroup upgraded the objective to $60.
π¦ Bruker maintains a market capitalization of $9.14 billion and a debt-to-equity ratio of 0.67.
π Revenue grew 2.7% year-over-year to $823.4 million, indicating continued top-line growth.
- Bruker Corporation beat analyst estimates for both earnings per share and revenue in the most recent quarter, demonstrating operational strength.
- The company provided FY 2026 guidance of $2.10-$2.15 EPS, which aligns perfectly with the average analyst expectation of $2.12.
- Revenue increased by 2.7% compared to the same quarter last year, showing consistent top-line growth.
- The firm maintains a positive return on equity of 11.60%, indicating efficient use of shareholder capital.
- Several institutional investors, including Parallel Advisors LLC and Allworth Financial LP, have increased their stakes in the company.
- Bank of New York Mellon Corp reduced its stake in Bruker by 6.6% in the first quarter, signaling a lack of confidence from a major institutional holder.
- The company reported a negative net margin of 0.65%, indicating profitability challenges despite revenue growth.
- Bruker's dividend payout ratio is -83.33%, reflecting that dividends are being paid out of reserves or cash flow rather than current earnings.